Lipidil and Joint swelling - a phase IV clinical study of FDA data

Summary:

Joint swelling is reported as a side effect among people who take Lipidil (fenofibrate), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Actemra, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Joint swelling when taking Lipidil. It is created by eHealthMe based on reports of 2,594 people who have side effects when taking Lipidil from the FDA, and is updated regularly.

What is Lipidil?

Lipidil has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 2,699 Lipidil users. Check the latest studies of Lipidil.

What is Joint swelling?

Joint swelling is found to be associated with 2,121 drugs and 2,938 conditions by eHealthMe. Check the latest studies of Joint swelling.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

2,594 people reported to have side effects when taking Lipidil.
Among them, 14 people (0.54%) have Joint swelling.

Among these 14 people:

How long have people been on Lipidil when they have Joint swelling? *

What is the gender of people who have Joint swelling when taking Lipidil? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Joint swelling when taking Lipidil? *

What are other drugs people take besides Lipidil? *

What are other side effects people have besides Joint swelling? *

Joint Pain: 12 people, 85.71%
Drug Ineffective: 9 people, 64.29%
Infusion Related Reaction: 8 people, 57.14%
Hot Flush (sudden feelings of heat): 6 people, 42.86%
Sinusitis (inflammation of sinus): 6 people, 42.86%
Pain: 6 people, 42.86%
Pain In Extremity: 6 people, 42.86%
Hypoaesthesia (reduced sense of touch or sensation): 5 people, 35.71%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 5 people, 35.71%
Fatigue (feeling of tiredness): 5 people, 35.71%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 57.14%
Diabetes: 3 people, 21.43%
High Blood Pressure: 2 people, 14.29%
Vasculitis (inflammation of a blood vessel or blood vessels): 1 person, 7.14%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 7.14%
Gastric Disorder (disease of stomach): 1 person, 7.14%
Dyslipidaemia (abnormal amount of lipids): 1 person, 7.14%
Constipation: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Lipidil and have Joint swelling?

- Check whether Joint swelling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lipidil:

Lipidil (2,699 reports)

Joint swelling treatments and more:

Joint swelling (143,797 reports)

Browse all side effects of Lipidil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint swelling:

Joint swelling (2,121 drugs)

Browse all the conditions that are associated with Joint swelling:

Joint swelling (2,938 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fenofibrate (the active ingredients of Lipidil) and Lipidil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.